Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kaspar

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Current Opinion in Biotechnology|July 12, 2005
Engineered proteins as specific binding reagentsH Kaspar Binz, Andreas Plückthun
Biological Psychology|March 1, 1994
Neuroendocrine and psychological effects of restricted environmental stimulation technique in a flotation tankP Schulz, C H Kaspar
Acta Hepato-Gastroenterologica|December 1, 1977
Study on lipid absorption in uraemiaH Sommer, H Kaspar, T Fösel
Annales De Medecine Interne|January 1, 1989
[Undesirable psychiatric effects of drugs]P Schulz, C H Kaspar, F Chardon
Nature Biotechnology|October 8, 2005
Engineering novel binding proteins from nonimmunoglobulin domainsH Kaspar Binz, Patrick Amstutz, Andreas Plückthun
Drug Discovery Today|July 16, 2008
DARPins: a new generation of protein therapeuticsMichael T Stumpp, H Kaspar Binz, Patrick Amstutz
Clinical and Experimental Obstetrics & Gynecology|February 13, 1999
Intrauterine insemination IUI: the effect of ovarian stimulation and infertility diagnosis on pregnancy outcomeA Hannoun, A Abu-Musa, H Kaspar, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 1, 1996
Premenarchal ovarian serous borderline tumor: a case report and review of the literatureM Seoud, F el-Kak, H Kaspar, et al.
European Journal of Gynaecological Oncology|July 20, 1999
Urothelial carcinoma of the vagina six years following cystectomy for invasive cancer. A case reportM A Bulbul, H Kaspar, R Nasr, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 26, 2020
Beyond Antibodies: The DARPin<sup>®</sup> Drug PlatformMichael T Stumpp, Keith M Dawson, H Kaspar Binz
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Current Opinion in Biotechnology|July 12, 2005
Engineered proteins as specific binding reagentsH Kaspar Binz, Andreas Plückthun
Biological Psychology|March 1, 1994
Neuroendocrine and psychological effects of restricted environmental stimulation technique in a flotation tankP Schulz, C H Kaspar
Acta Hepato-Gastroenterologica|December 1, 1977
Study on lipid absorption in uraemiaH Sommer, H Kaspar, T Fösel
Annales De Medecine Interne|January 1, 1989
[Undesirable psychiatric effects of drugs]P Schulz, C H Kaspar, F Chardon
Nature Biotechnology|October 8, 2005
Engineering novel binding proteins from nonimmunoglobulin domainsH Kaspar Binz, Patrick Amstutz, Andreas Plückthun
Drug Discovery Today|July 16, 2008
DARPins: a new generation of protein therapeuticsMichael T Stumpp, H Kaspar Binz, Patrick Amstutz
Clinical and Experimental Obstetrics & Gynecology|February 13, 1999
Intrauterine insemination IUI: the effect of ovarian stimulation and infertility diagnosis on pregnancy outcomeA Hannoun, A Abu-Musa, H Kaspar, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 1, 1996
Premenarchal ovarian serous borderline tumor: a case report and review of the literatureM Seoud, F el-Kak, H Kaspar, et al.
European Journal of Gynaecological Oncology|July 20, 1999
Urothelial carcinoma of the vagina six years following cystectomy for invasive cancer. A case reportM A Bulbul, H Kaspar, R Nasr, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 26, 2020
Beyond Antibodies: The DARPin<sup>®</sup> Drug PlatformMichael T Stumpp, Keith M Dawson, H Kaspar Binz
Pageof 6